Under the leadership of Professor Alan Melcher, we are seeking to appoint a Scientific Officer to join the Centre for Translational Immunotherapy and Radiation Research Network to work in human immunology/immunotherapy research, focussed on management, processing and analysis of clinical patient samples.
This role is eligible for ICR Sponsorship. Support will be provided for costs associated with Visa application.
Key requirements
The successful candidate must have a BSc. (or equivalent) in a biological science, knowledge of immunology and proven experience in laboratory work and molecular biology techniques.
Department/Directorate information
The Division of Radiotherapy and Imaging brings together research groups that work on how to use radiation therapy, guided by state-of-the-art imaging techniques, in the most effective way to cure cancer. Our work is based on the central idea that the best outcomes will be achieved by delivering curative radiation doses to tumours, while limiting radiation damage of neighbouring normal tissues. Our therapy often includes adding drug treatments alongside radiation therapy as a means of killing cancer cells more effectively and, at the same time, activating anti-tumour immune responses.
Preclinical work includes research that combines radiation therapy with radiation sensitisers and biological response modifiers (oncolytic viruses, innate immune activators, immune checkpoint inhibitors) to maximise anti-tumour efficacy and give protection against tumour recurrence. Multiple translational clinical studies seek to address these themes through our collaborators in The Royal Marsden NHS Foundation Trust (RM). Overall, our mission is to cure more patients with fewer immediate and long-term side effects of treatment.
TheCentre for Translational Immunotherapy (CTI) is led by Prof. Alan Melcher. The CTI has been established to co-ordinate immunology and immunotherapy research across the ICR and RM and provide supporting infrastructure. We have a particular interest in the immune consequences of radiotherapy treatment. The CTI spans the full range of translational research from basic science/pre-clinical modelling to analysis of patient samples. This post will be focused towards the patient end of this spectrum, related to the processing and study of clinical samples.
Why work for us?
As a member of staff, you'll have exclusive access to a range of staff benefits. The ICR is committed to supporting overseas applicants applying for roles. The Institute of Cancer Research, London, is one of the world's most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years.
We look forward to receiving applications from all candidates, wherever in the world they are currently based. We will select those who display the potential to become, or to support, the world leading cancer researchers of the future based on their application and performance at interview. However, we particularly welcome British applicants from black and ethnic minority backgrounds, as they are under-represented within the ICR and nationwide in STEM roles.